Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol. 2009 Oct; 51(4):725-33.
View in:
PubMed
subject areas
Animals
Antineoplastic Combined Chemotherapy Protocols
Benzenesulfonates
Carcinoma, Hepatocellular
Cell Line, Tumor
Cell Proliferation
DNA Methylation
Drug Synergism
Female
Gene Dosage
Genes, ras
Humans
Liver Neoplasms
Liver Neoplasms, Experimental
Mice
Mice, Nude
Neoplasm Transplantation
Niacinamide
Phenylurea Compounds
Promoter Regions, Genetic
Protein Kinases
Pyridines
ras Proteins
RNA, Messenger
RNA, Neoplasm
Signal Transduction
Sirolimus
TOR Serine-Threonine Kinases
Transplantation, Heterologous